CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Voyager Therapeutics

For profitWebsite ↗

Also known as: Voyager Therapeutics | Voyager Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 30, 2021

Timeline

2010s

Jun 1, 2013
Voyager Therapeutics— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

vy-aadc02

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT04885114Lead sponsorPhase 1Jul 30, 2021
NCT03562494Lead sponsorPhase 2Jun 28, 2018
NCT03562494Study directorPhase 2Jun 28, 2018
NCT03065192Study directorPhase 1May 11, 2017
NCT03065192Lead sponsorPhase 1May 11, 2017
NCT01973543Study directorPhase 1Oct 1, 2013
NCT01973543Lead sponsorPhase 1Oct 1, 2013

Details

Founded: Cambridge, MA, US Jun 1, 2013
Last known activity: Jul 30, 2021